Cargando…

Microvascular Shunts in COVID-19 Pneumonia

Detalles Bibliográficos
Autores principales:	Bush, Douglas, Abman, Steven H., Galambos, Csaba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887413/ https://www.ncbi.nlm.nih.gov/pubmed/35533392 http://dx.doi.org/10.1164/rccm.202111-2627LE

Ejemplares similares

Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure
por: Galambos, Csaba, et al.
Publicado: (2021)

Intrapulmonary Bronchopulmonary Anastomoses in Severe COVID-19–related Acute Respiratory Failure
por: Bodmer, Jenna, et al.
Publicado: (2022)

Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intrapulmonary Shunts in Response to Microvascular Occlusion
por: Cherian, Robin, et al.
Publicado: (2021)

Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension
por: Galambos, Csaba, et al.
Publicado: (2016)

Reply to Cherian et al.: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intrapulmonary Shunts in Response to Microvascular Occlusion
por: Reynolds, Alexandra S., et al.
Publicado: (2021)

Treatment of COVID-19 by Inhaled NO to Reduce Shunt?
por: Hedenstierna, Göran, et al.
Publicado: (2020)

Angiogenic profile identifies pulmonary hypertension in children with Down syndrome
por: Bush, Douglas, et al.
Publicado: (2019)

Microvascular Injury in the Brains of Patients with Covid-19
por: Lee, Myoung-Hwa, et al.
Publicado: (2020)

COVID-19 May Be Exacerbated by Right-to-Left Interatrial Shunt
por: Rajendram, Rajkumar, et al.
Publicado: (2021)

Microvascular disease in diabetes and severe COVID-19 outcomes
por: Corcillo, Antonella, et al.
Publicado: (2021)

Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema
por: Le Cras, Timothy D., et al.
Publicado: (2020)

Right-to-Left Interatrial Shunt in COVID-19 Patients With Pulmonary Embolism: Reply
por: Fabre, Olivier, et al.
Publicado: (2021)

Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19
por: Jaunmuktane, Zane, et al.
Publicado: (2020)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Biochemical shunt: where and how?
por: Busana, Mattia, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Status of congenital extrahepatic portosystemic shunt
por: Zeng, Pan, et al.
Publicado: (2022)

Reply: Intrapulmonary shunt and alveolar dead space in a cohort of patients with acute COVID-19 pneumonitis and early recovery
por: Harbut, Piotr, et al.
Publicado: (2023)

Comment on: Intrapulmonary shunt and alveolar dead space in a cohort of patients with acute COVID-19 pneumonitis and early recovery
por: Ackermann, Maximilian, et al.
Publicado: (2023)

Severe Hypoxemia in Early COVID-19 Pneumonia
por: Bhatia, Pradeep, et al.
Publicado: (2020)

COVID-19 and complicated bacterial pneumonia in children
por: Kaddour, Mohamad, et al.
Publicado: (2021)

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
por: Sauteur, Patrick M Meyer, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Microvascular dysfunction in silent myocardial ischemia
por: Han, Chih-Lu, et al.
Publicado: (2017)

Familial cluster of pneumonia and asymptomatic cases of COVID-19 in Taiwan
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

Provision of holistic care after severe COVID-19 pneumonia
por: McPeake, Joanne, et al.
Publicado: (2021)

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?
por: Blot, Mathieu, et al.
Publicado: (2021)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Role of bronchoscopy in critically ill patients with COVID-19 pneumonia()
por: Díez-Ferrer, M., et al.
Publicado: (2021)

Epicardial adipose tissue in coronary microvascular dysfunction
por: Duyuler, Serkan, et al.
Publicado: (2022)

Pneumonia amidst the COVID‐19 pandemic in Africa: Challenges and possible solutions
por: Uwishema, Olivier, et al.
Publicado: (2022)

Effect of proning and recruitment on physio-anatomical variables in COVID-19 pneumonia
por: Gurjar, Mohan, et al.
Publicado: (2022)

Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia
por: Garfield, Benjamin, et al.
Publicado: (2021)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
por: Elabbadi, Alexandre, et al.
Publicado: (2021)

Interpretation of the transpulmonary thermodilution curve in the presence of a left-to-right shunt
por: Nusmeier, Anneliese, et al.
Publicado: (2010)

Noninvasive CSF shunt patency evaluation by superb microvascular imaging
por: Putzer, D., et al.
Publicado: (2023)

Urinary Phosphate Excretion and Microvascular Function in a Population-Based Cohort
por: Ginsberg, Charles, et al.
Publicado: (2020)

Pulmonary Vascular Dilatation Detected by Automated Transcranial Doppler in COVID-19 Pneumonia
por: Reynolds, Alexandra S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gn3th4r7o2pbm4k5ng0ghrg3nj